Page last updated: 2024-10-29

imipramine and Female Genital Neoplasms

imipramine has been researched along with Female Genital Neoplasms in 2 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Evans, DL1
McCartney, CF1
Nemeroff, CB1
Haggerty, JJ1
Simon, JS1
Pedersen, CA1
Holmes, V1
Droba, M1
Mason, GA1
Raft, D1
Mönkemeier, D1
Steffen, U1

Reviews

1 review available for imipramine and Female Genital Neoplasms

ArticleYear
Depression in cancer patients. Diagnostic and treatment considerations.
    North Carolina medical journal, 1988, Volume: 49, Issue:10

    Topics: Depressive Disorder; Dexamethasone; Female; Genital Neoplasms, Female; Imipramine; Neoplasms; Pilot

1988

Other Studies

1 other study available for imipramine and Female Genital Neoplasms

ArticleYear
[The management of pain with imipramine in cancer].
    Medizinische Klinik, 1970, Jan-30, Volume: 65, Issue:5

    Topics: Dextromoramide; Female; Genital Neoplasms, Female; Humans; Imipramine; Kidney Function Tests; Liver

1970